Archive

Antidepressant prescribing during covid-19

Written by | 2 Jul 2021

Some four million extra prescriptions for antidepressants were issued in 2020 compared to 2019 but the cost to the NHS increased by £139 million, according to a study published in […]

How pharmacist prescribers will tackle polypharmacy

Written by | 13 May 2021

Drs Claire Scullin and Joanne Brown describes how prescribing pharmacists will carry out in-depth medication reviews for hospital inpatients and make any changes needed to prescriptions as part […]

The problems with polypharmacy

Written by | 12 May 2021

Polypharmacy, or the concomitant use of multiple medicines, is estimated to cost $18 billion and account for 8.6 million hospital admissions annually in the European Union. The iSIMPATHY […]

Real world evidence from Peru and Colombia confirms ivermectin safe and effective

Written by | 27 Mar 2021

The real world evidence about ivermectin combined with the findings from meta-analyses of clinical trials provide compelling evidence for the safety and effectiveness of ivermectin, according to Dr […]

Colombian ivermectin study – how protocol violations influenced results

Written by | 26 Mar 2021

The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin, according to Dr David Scheim. https://www.youtube.com/watch?v=T67szXgTqWw&ab_channel=MedicalUpdateOnline […]

Protocol violations in Colombian ivermectin study compromise results

Written by | 25 Mar 2021

Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent controlled trial of ivermectin for covid-19 […]

Ivermectin in Peru – results that save lives

Written by | 24 Mar 2021

Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as a result of intensive ivermectin distribution. […]

Analysis confirms 14 fold reduction in deaths with Ivermectin treatment in Peru

Written by | 23 Mar 2021

Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a 14-fold reduction in excess deaths. IMI interviewed Dr […]

Ivermectin mass treatment in perspective

Written by | 17 Feb 2021

Ivermectin is a good treatment to use interim to and complementary to immunisations, according to Dr David Scheim, one of the authors of a study of mass treatment for covid-19 […]

Ivermectin dosing and distribution for mass treatment

Written by | 16 Feb 2021

Dr David Scheim, one of the authors of a recent study in Peru, describes the doses of ivermectin that were used and the strategies for effective mass distribution. https://www.youtube.com/watch?v=MSkKU18VlNo […]

The impact of covid-19 on lung cancer care

Written by | 4 Feb 2021

Delayed diagnoses and more patients with advanced cancers were consequences of the coronavirus pandemic, according to Dr Erin Schenk, Assistant Professor, Thoracic Oncology, University of Colorado. The coronavirus […]

The changing treatment landscape in lung cancer

Written by | 3 Feb 2021

Modern lung cancer treatment has changed the outlook for lung cancer patients considerably and interesting trial results are expected this year, according to Dr Erin Schenk, Assistant Professor, […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.